医药产业是创新的支柱产业之一。医药创新不仅可为经济发展提供长久动力，也是解决民生问题的根本要求。最近，中国医药企业管理协会、中国化学制药工业协会、中国医药保健品进出口商会、中国外商投资企业协会药品研制和开发行业委员会联合呼吁：在未来十年到二十年，提升医药创新对经济发展和民生的价值，关键是构建可持续发展的医药创新生态系统。中国必须依靠发展创新产业，实现从医药大国向医药强国的转变。

目前，“二次议价”“两票制”甚至“一票制”的广泛开展运作已成定局，大型药企独立市场开发和大中型药企业兼并也大势所趋，可以说，医药代表在上层开发或代理已经没有多大的平台与机遇，应该到基层探讨、调研与开发基层医药市场，了解基层医药市场变化，寻找医药销售渠道，开发终端客户。

In spite of tremendous improvements made over the past decade for the treatment of ophthalmology diseases and conditions, there remains a dramatic unmet medical need for treatments that can stop apoptosis of important retinal cells, including photoreceptors. We believe that developing new therapies in this ophthalmology area is positioned as the next frontier in ophthalmology drug development. Both dry and wet forms of AMD conditions may lead to vision loss due to the lack of treatments that are capable of preventing the death of the main retinal cells. Therefore, there is a huge market for a treatment that is capable of protecting vision by preventing the apoptosis of retinal cells, which is related to various forms of AMD.

There will be a paradigm shift toward next-generation miniaturized point-of-care (POC) coagulation testing devices during the forecast period. It is expected that these new devices will replace the traditional coagulation devices due to their low cost and effectiveness.Next-generation polymer nanocomposite-based electrochemical biosensors will replace the traditional electrochemical biosensors due to their compact size, high accuracy, and low cost.

Anterior cervical fixation is performed surgically to treat damaged/herniated discs that cause compression of spinal cord or nerve root. The surgery stabilizes the corresponding vertebrae, and the pain is decompressed by fixing the anterior fixation system with essential anterior plating, screws, and implants.

The advances in technology such as high-content screening (HCS) for drug discovery processes in the pharmaceutical and biopharmaceutical industry will lead to the development of new and more effective products for detection of oxidative stress in cells, in turn, leading to a rise in demand for consumables, including reagents and markers.Oxidative stress detection services are being offered by many sub-contract laboratories, with several new contract laboratories being set up, to cater to the pharmaceutical industry. The major source of demand is likely to shift from pharmaceutical companies to these laboratories.The current market landscape for oxidative stress detection is prone to disruptions due to the introduction of breakthrough technologies in this field. With several companies gradually investing in biotechnology, the market is highly volatile in terms of products as well as series.

Adult stores generally refer to retail outlets that are involved in the business of providing a wide range of products such as sex toys, personal lubricants, and erotic lingerie under broad categories such as clothing and pornography. These are sexual stimulation products available in different types, sizes, and colors and are used to augment pleasure.

This Technavio report covers the present scenario and growth prospects of the global neurological biomarkers market for 2016-2020 (base year: 2015). The revenue generated from the sales of neurological biomarkers are considered to estimate the market size.Note: All values are rounded off. Due to rounding off, some totals may not correspond with the sum/computation of the separate figures.This market is classified based on two product types: consumables and services.Based on the indications wherein these biomarkers are used, they are classified as Alzheimer's disease (AD), multiple sclerosis (MS), autism spectrum disorder (ASD),and Parkinson's disease (PD). Biomarkers are used in various applications such as genomics, proteomics, metabolomics, and imaging. Based on the end-users of these biomarkers, they are classified as hospitals, research laboratories, and diagnostic laboratories.The report also focuses on the vendor landscape of manufacturers, which provides new developments and an exclusive analysis about top vendors of the market. In addition, the report focuses on the market as a whole, the major drivers influencing market growth, and the challenges faced by vendors. The influence of key emerging trends on current and future market scenarios are also discussed in this report.

The increasing use of multiparameter patient monitoring equipment for remote monitoring applications is expected to fuel the market growth. For instance, the number of individuals using remote monitoring stood at approximately 890,000 in 2015 and is projected to reach four million by 2020. The broader applications of multiparameter patient monitoring equipment in emergency and intensive care unit (ICU) departments and other emerging applications such as mobile and ambulatory care are expected to increase the demand further. The applicability of patient monitoring in mobile and ambulatory care will fuel the adoption of wireless and portable multiparameter patientmonitoring equipment.

The global pet daycare and lodging market is expected to grow at a CAGR of 8.26% during the forecast period. The market is driven by premiumization of pet services and the increasing number of restaurants and hotels for pets.Cat daycare and lodging services are less popular than dog daycare and lodging services or combined pet daycare and lodging services. This is because cats prefer to be kept in their own environment; as a result, pet owners prefer in-house pet sitters for their cats.Strategic alliances such as mergers and acquisitions are leading to an increase in pet daycare and lodging facilities, especially in the US. This increase in the number of pet-care facilities attributed to the rising number of pet owners who like to pamper their pets with luxurious services. In 2016, Paradise 4 Paws Pet Resort took over the operations of Petco's Pooch Hotel. The resort operates all 10 Petco's Pooch Hotels as well as four of its existing pet resorts in the US.

Hospital-spread infections (HSI) pose a major threat to patients’ safety. Organizations such as Centers for Disease Control and Prevention (CDC) and Public Health England track the healthcare settings to identify the infection type and make efforts toward prevention through routine surveillance programs. According to the CDC, one in 25 individuals in the US, in 2015, suffered from HAI during hospital care. Healthcare personnel recommend the use of disposable anesthesia devices such as laryngeal mask airways (LMA), face masks, breathing circuits, ETT and resuscitators to prevent HAI during surgical procedures involving general anesthesia. Anesthesia disposables are single-use consumables.

Anesthesia is a way to control pain during surgery or other painful procedures like getting stitches using anesthetics. It can help maintain control over breathing, blood pressure, blood flow, and heart rate of the individual undergoing the procedure. This is because anesthesia can help an individual to relax by blocking pain and make them unconscious during surgery. Anesthetics are administered to individuals through an injection or through inhaled gases or vapors.

The growing incidence of brain aneurysm and cerebral disorders is expected to drive the market growth. For instance, in 2014, approximately six million individuals were affected by an unruptured cerebral aneurysm in the US. Also, approximately 0.7 million strokes occur every year in the US.The rising demand for minimally invasive procedures is expected to fuel the adoption rates for neuroendovascular non-coils, owing to lesser complications.Therefore, neurosurgeons are shifting from their traditional approaches (surgical clipping) to advanced minimally invasive surgeries. Vendors are also focusing on developing minimally invasive devices. For instance, in February 2015, Medtronic received the US FDA approval for its flow diversion Pipeline Embolization Device,which is used for treating brain aneurysm. It is the first flow diversion device to receive approval from the US FDA.

An anesthesia delivery system, which includes anesthesia machine and a breathing circuit, supports in pain management just before the surgical (pre-surgical) procedure. The anesthesia machine includes an anesthesia vaporizer, where the vaporizer mixes both anesthetic agent and oxygen together and delivers to the individual during the pre-surgical procedure through breathing circuit. Various factors such as the increasing number of surgical procedures, growing number of specialty hospitals, and hospital mergers and acquisitions (M&A) are accelerating the global anesthesia vaporizers market growth.

2017 年国家新版医保目录发布，根据我们统计，此次新版医保目录新增化药品种133 个，新增中成药品种251 个。对于首次纳入的重点品种，放量值得期待。后续医保部门还会启动医保药品谈判准入机制，对于符合条件的药品纳入医保支付范围，名单另行发布。

近年医药行业全产业（研发-生产-流通-销售）的政策导向就是规范运营，加强监管，预计在两票制等多重政策影响下，医药流通领域集中度将会加速提升。其中药品流通领域经过多年整合，已基本形成（国药、上药、华润）+九州通+区域龙头的格局。而壁垒更高的高值耗材流通领域整合的序幕才刚刚开启，目前全国 1200 亿元左右的规模，市场更加分散，整合空间更大，而且利润空间更高。

近 5 个交易日市场整体呈现出震荡态势，沪深 300 指数下跌 0.86%，申万 一级行业则涨跌互现，在 28 个行业之中有 15 个行业取得正收益。医药生 物行业上涨 0.63%，跑赢沪深 300 指数。子行业除医疗服务以外均以上涨 报收，其中化学制药行业上涨 0.98%。截至 2 月 28 日，申万医药生物行 业市盈率（TTM 整体法，剔除负值）为 40.58 倍，化学制药行业市盈率为 42.60 倍；相对于全体 A 股（剔除银行股）市盈率的溢价率分别为 30.90% 和 37.42%，估值和溢价率相比于上周均有所上升。个股涨跌幅方面，易 明医药、特一药业和赛托生物涨幅居前；司太立、丽珠集团和鲁抗医药领 跌板块。

2017 年 2 月 23 日，人社部发布《关于印发〈国家基本医疗保险、工伤保险和生育保险药品目录（2017 年版）〉的通知》，时隔八年，一直牵动整个医药行业的医保目录调整方案最终尘埃落定。

上周人社部公布新版医保目录，受此影响，医药板块上涨 3.09%，涨幅居前。上一次医保目录调整后一年内，医药板块走出了独立行情，我们认为，虽然此次医保目录调整是在医保控费，行业增速已远不及 2009 年调整时的行业增速背景下发生的，但正是此前极低的板块预期，处于近年来低点的估值溢价率，以及较为确定的相对有优势的行业增速，使得后市医药板块走势在这一重磅事件催化下可能强于大盘。

新版医保目录反映了当前医药行业发展特征，也反映了当前重点关注的疾病防治脉络。根据以往医保目录颁布情况来看，新进品种可能在未来 1-3 年迅速放量，部分临床急需、疗效明确的品种可能获得较大的增长，其中包括一些老的重大品种。对比历史数据情况来看，2009年公布医保目录名单，在此后的半年内，医药板块呈上行趋势，半年涨幅为 12.76%。而医保目录公布之后的一年，医药指数在此期间的涨幅为 45.70%。